Annual Accounts Receivable
$1000.00
-$3000.00-75.00%
December 31, 2023
Summary
- As of February 7, 2025, TCRT annual accounts receivable is $1000.00, with the most recent change of -$3000.00 (-75.00%) on December 31, 2023.
- During the last 3 years, TCRT annual accounts receivable has fallen by -$4.66 million (-99.98%).
- TCRT annual accounts receivable is now -99.98% below its all-time high of $4.67 million, reached on December 31, 2020.
Performance
TCRT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$0.00
-$4000.00-100.00%
September 30, 2024
Summary
- As of February 7, 2025, TCRT quarterly accounts receivable is $0.00, with the most recent change of -$4000.00 (-100.00%) on September 30, 2024.
- Over the past year, TCRT quarterly accounts receivable has dropped by -$4000.00 (-100.00%).
- TCRT quarterly accounts receivable is now -100.00% below its all-time high of $7.63 million, reached on June 30, 2021.
Performance
TCRT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TCRT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -75.0% | -100.0% |
| 3 y3 years | -100.0% | -100.0% |
| 5 y5 years | -100.0% | -100.0% |
TCRT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -99.9% | at low | -100.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | +100.0% | -100.0% | at low |
Alaunos Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) |
| Jun 2024 | - | $4000.00(+300.0%) |
| Mar 2024 | - | $1000.00(0.0%) |
| Dec 2023 | $1000.00(-75.0%) | $1000.00(>+9900.0%) |
| Sep 2023 | - | $0.00(-100.0%) |
| Jun 2023 | - | $4000.00(>+9900.0%) |
| Mar 2023 | - | $0.00(-100.0%) |
| Dec 2022 | $4000.00(-99.6%) | $4000.00(-99.9%) |
| Sep 2022 | - | $2.91 M(>+9900.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $1.11 M(-76.2%) | $1.11 M(-26.4%) |
| Sep 2021 | - | $1.51 M(-80.2%) |
| Jun 2021 | - | $7.63 M(+52.3%) |
| Mar 2021 | - | $5.01 M(+7.3%) |
| Dec 2020 | $4.67 M(+40.1%) | $4.67 M(-14.1%) |
| Sep 2020 | - | $5.43 M(+33.3%) |
| Jun 2020 | - | $4.07 M(+420.7%) |
| Mar 2020 | - | $782.00 K(-76.5%) |
| Dec 2019 | $3.33 M(+78.6%) | $3.33 M(-3.2%) |
| Sep 2019 | - | $3.44 M(+135.7%) |
| Jun 2019 | - | $1.46 M(+71.0%) |
| Mar 2019 | - | $854.00 K(-54.2%) |
| Dec 2018 | $1.86 M | $1.86 M(+82.6%) |
| Sep 2018 | - | $1.02 M(+54.0%) |
| Jun 2018 | - | $663.00 K(+3583.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $18.00 K(-5.3%) |
| Dec 2017 | $19.00 K(-9.5%) | $19.00 K(+46.2%) |
| Sep 2017 | - | $13.00 K(-70.5%) |
| Jun 2017 | - | $44.00 K(-34.3%) |
| Mar 2017 | - | $67.00 K(+219.0%) |
| Dec 2016 | $21.00 K(-95.3%) | $21.00 K(-16.0%) |
| Sep 2016 | - | $25.00 K(+66.7%) |
| Jun 2016 | - | $15.00 K(-98.6%) |
| Mar 2016 | - | $1.06 M(+137.7%) |
| Dec 2015 | $446.00 K(+207.6%) | $446.00 K(+20.9%) |
| Sep 2015 | - | $369.00 K(+314.6%) |
| Jun 2015 | - | $89.00 K(+43.5%) |
| Mar 2015 | - | $62.00 K(-57.2%) |
| Dec 2014 | $145.00 K(0.0%) | $145.00 K(-30.3%) |
| Sep 2014 | - | $208.00 K(+550.0%) |
| Jun 2014 | - | $32.00 K(+18.5%) |
| Mar 2014 | - | $27.00 K(-81.4%) |
| Dec 2013 | $145.00 K(+150.0%) | $145.00 K(-67.7%) |
| Sep 2013 | - | $449.00 K(+1348.4%) |
| Jun 2013 | - | $31.00 K(-56.9%) |
| Mar 2013 | - | $72.00 K(+24.1%) |
| Dec 2012 | $58.00 K(-26.6%) | $58.00 K(-26.6%) |
| Dec 2011 | $79.00 K(>+9900.0%) | $79.00 K(+7800.0%) |
| Jun 2002 | - | $1000.00(+100.0%) |
| Dec 2001 | $500.00 | $500.00(0.0%) |
| Sep 2001 | - | $500.00 |
FAQ
- What is Alaunos Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual accounts receivable year-on-year change?
- What is Alaunos Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly accounts receivable year-on-year change?
What is Alaunos Therapeutics annual accounts receivable?
The current annual accounts receivable of TCRT is $1000.00
What is the all time high annual accounts receivable for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual accounts receivable is $4.67 M
What is Alaunos Therapeutics annual accounts receivable year-on-year change?
Over the past year, TCRT annual accounts receivable has changed by -$3000.00 (-75.00%)
What is Alaunos Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of TCRT is $0.00
What is the all time high quarterly accounts receivable for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly accounts receivable is $7.63 M
What is Alaunos Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, TCRT quarterly accounts receivable has changed by -$4000.00 (-100.00%)